Skip to main content
. 2020 Jul 20;21(14):5137. doi: 10.3390/ijms21145137

Figure 2.

Figure 2

Ruxolitinib suppressed interferon (IFN)-γ-induced expressions of caspase-1, interleukin (IL)-1 β, and IL-15. The mRNA expression of (A) caspase-1, (B) IL-1 β, (C) IL-15, and (D) IL-18 in hDPCs. The data represent the means ± SEM, n = 4, statistically significant at * p < 0.05, ** p < 0.01, *** p < 0.001 compared to control, and # p < 0.05, ## p < 0.01, ### p < 0.001 compared with IFN-γ-treated group.